Zev Aryeh Wainberg MD

Professor, Medicine, UCLA School of Medicine

2020 Santa Monica Blvd., Suite 600Santa Monica, CA 90404
Phone+1 310-570-1472
Fax+1 310-570-1472

Dr. Wainberg is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wainberg's full profile Already have an account?

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2000 - 2003
Tel Aviv University SacklerClass of 2000

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2003 - 2027
NY State Medical License 2001 - 2003
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017

Clinical Trials

Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia
COMPLETED
PHASE2
Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer
COMPLETED
PHASE2
Safety Study of PLX108-01 in Patients With Solid Tumors Start of enrollment: 2009 Oct 01
COMPLETED
PHASE1

Publications & Presentations

PubMed

Sirexatamab in Combination with Bevacizumab and Chemotherapy as Second-Line Therapy for Advanced Colorectal Adenocarcinoma: the Phase II DeFianCe Trial.
Zev A Wainberg, Keun-Wook Lee, Jong Gwang Kim, Craig Devoe, John H Strickler
Clinical Cancer Research. 2026-07-23
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.
Eileen M O'Reilly, Zev A Wainberg, Andrew E Hendifar, Mitesh J Borad, Filippo Pietrantonio
The New England Journal of Medicine. 2026-07-23
The Randomized Phase II ARC-9 Study of Etrumadenant-Based Therapy versus Regorafenib in Patients with Previously Treated Metastatic Colorectal Cancer.
Michael Cecchini, Sae-Won Han, Soohyeon Lee, Keun-Wook Lee, Scott Kopetz
Clinical Cancer Research. 2026-07-01

Journal Articles

Efficacy and Safety of Pembrolizumab or Pembrolizumab plus Chemotherapy vs Chemotherapy Alone for Patients with First-Line, Advanced Gastric Cancer
Al Benson, Zev A Wainberg, JAMA Oncology

Lectures

First-line durvalumab + monalizumab, mFOLFOX6, and bevacizumab or cetuximab for metastatic microsatellite-stable colorectal cancer (MSS-CRC).
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
Efficacy of pembrolizumab (pembro) monotherapy versus chemotherapy for PD-L1–positive (CPS ≥10) advanced G/GEJ cancer in the phase II KEYNOTE-059 (cohort 1) and phase ...
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
Efficacy and safety of pembrolizumab (pembro) alone or in combination with chemotherapy (chemo) in patients (pts) with advanced gastric or gastroesophageal (G/GEJ) can...
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Experimental Pill Promises New Hope for Deadly Pancreatic CancerMay 31st, 2026
Why Your Back Pain Could Be a Sign of Something More SeriousNovember 24th, 2025
ESMO: 10-Year Survival Data for Lung Cancer Immunotherapy, New PSMA-Targeted Therapy for Recurrent Prostate Cancer, Promising Results in Metastatic Colorectal and Urothelial CancersOctober 20th, 2025

Grant Support

Causes and Consequences of Adenosine Signaling in Pancreatic CancerUNIVERSITY OF CALIFORNIA LOS ANGELES2024–2029
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancerUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2026